Pain Management Therapeutics Market, By Type of Pain (Acute Pain, Chronic Pain, Cancer Pain, Neuropathic Pain, and Postoperative Pain), By Drug Class, By Administration Route, By End-user, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Pain Management Therapeutics Market size was valued at US$ 84,978 Million in 2024, expanding at a CAGR of 3.78% from 2025 to 2032.
The Pain Management Therapeutics Market encompasses treatments and medications aimed at alleviating or reducing pain associated with a variety of medical conditions. This market includes a broad spectrum of products, such as opioids, non-opioid analgesics, anti-inflammatory drugs, topical agents, and advanced therapies like nerve blocks and neuromodulation. The primary objective is to enhance patient quality of life by effectively managing both acute and chronic pain.
Key factors driving this market include the increasing prevalence of chronic diseases, an aging global population, and growing awareness of available pain management options. Advances in drug formulations and delivery technologies are expanding therapeutic possibilities, while the rising demand for safer, non-addictive pain relief alternatives is influencing market trends. The market addresses pain related to conditions such as cancer, arthritis, neuropathic disorders, and postoperative recovery. Overall, this sector plays a vital role in healthcare by tackling one of the most common and challenging symptoms experienced worldwide.
Pain Management Therapeutics Market- Market Dynamics
Growing demand for non-opioid pain relief is driving the development of safer therapeutic alternatives.
The rising demand for non-opioid pain relief is a key driver of the Pain Management Therapeutics Market. Growing concerns about opioid addiction, misuse, and adverse side effects have prompted patients and healthcare providers to seek safer alternatives. Non-opioid therapies—including NSAIDs, anticonvulsants, antidepressants, and topical treatments—offer effective pain relief with a lower risk of dependency and side effects.
This shift is further supported by increased awareness campaigns and stricter global regulations on opioid prescriptions. Governments worldwide are implementing policies to combat the opioid crisis, such as the U.S. Centers for Disease Control and Prevention (CDC) guidelines on opioid prescribing and similar initiatives in Canada, Europe, and Australia. These efforts encourage the use of safer pain management alternatives. Advances in research are also leading to the development of innovative non-opioid drugs that target pain more precisely. Consequently, the market is expanding its portfolio to include these safer options. This trend is particularly crucial in managing chronic pain conditions, where prolonged opioid use can be problematic. Overall, the growing preference for non-opioid therapies is transforming pain management approaches and driving market growth globally.
Pain Management Therapeutics Market- Key Insights
- According to our research analyst’s analysis, the global market is projected to grow at a compound annual growth rate (CAGR) of approximately 3.78% during the forecast period from 2025 to 2032.
- In 2024, the Chronic Pain segment held the largest market share based on Type of Pain segmentation.
- Opioids were the leading drug class in 2024 according to the Drug Class segmentation.
- For Administration Route segmentation, Oral administration was the dominant distribution channel in 2024.
- Hospitals emerged as the primary end-user segment in 2024.
- Regionally, North America was the top revenue generator in 2024.
Pain Management Therapeutics Market- Segmentation Analysis:
The Global Pain Management Therapeutics Market is segmented on the basis of Type of Pain, Drug Class, Distribution, End-user, and Region.
The Pain Management Therapeutics Market is segmented based on the type of pain into Acute Pain, Chronic Pain, Cancer Pain, Neuropathic Pain, and Postoperative Pain. Among these, chronic pain represents the dominant segment due to its widespread prevalence and persistent nature. Unlike acute pain, which is temporary and typically associated with injury or surgery, chronic pain lasts for months or even years, often stemming from conditions such as arthritis, neuropathy, or fibromyalgia. Managing chronic pain poses significant challenges because it severely impacts patients’ quality of life and daily functioning, driving demand for effective and sustainable pain relief therapies. According to the Centers for Disease Control and Prevention (CDC), nearly 20% of U.S. adults suffer from chronic pain, highlighting the substantial public health burden. Additionally, the aging global population and the rising incidence of chronic diseases further amplify the need for innovative treatments specifically targeting chronic pain, fueling growth in this market segment.
The market is also categorized by drug class into Opioids, Non-Opioid Analgesics, Adjuvant Analgesics, Topical Analgesics, and others. Opioids continue to dominate the Pain Management Therapeutics Market due to their potent effectiveness in alleviating moderate to severe pain. These drugs work by binding to opioid receptors in the brain and spinal cord, significantly diminishing pain perception. Despite their efficacy, the risk of addiction and adverse side effects has led to increased regulatory scrutiny and more cautious prescribing practices. Nevertheless, opioids remain widely used, especially in managing cancer pain and postoperative pain. The U.S. Food and Drug Administration (FDA) reports that over 191 million opioid prescriptions were dispensed in recent years, underscoring their continued prevalence. Furthermore, ongoing research and development efforts focus on creating safer opioid formulations that provide effective pain relief while minimizing the risk of dependency, thereby sustaining opioids’ critical role in pain therapeutics.
Pain Management Therapeutics Market- Geographical Insights
North America holds a dominant position in the Pain Management Therapeutics Market, supported by its well-established healthcare infrastructure and the high prevalence of chronic pain conditions. The United States leads the region, driven by a growing incidence of arthritis, cancer, and neuropathic pain, particularly among its aging population. Increasing awareness of pain management options and the widespread adoption of advanced therapies further contribute to market growth. Additionally, regulatory agencies in the region are encouraging safer pain management practices, accelerating the shift toward non-opioid alternatives.
Within North America, the United States is the largest contributor to the Pain Management Therapeutics Market. This is fueled by the high prevalence of chronic pain conditions and an aging demographic. Rising concerns about opioid addiction have heightened demand for safer, non-opioid pain relief solutions. The country’s robust healthcare infrastructure, cutting-edge research, and government initiatives supporting improved pain management collectively drive market expansion. Furthermore, the presence of leading pharmaceutical companies fosters ongoing innovation in pain therapeutics.
Pain Management Therapeutics Market- Competitive Landscape:
The Pain Management Therapeutics Market is highly competitive, marked by intense rivalry among leading pharmaceutical and biotech companies. Key players focus on product innovation, strategic partnerships, and acquisitions to strengthen their market positions. Significant investments in research and development are driving the creation of safer, more effective pain relief options—especially non-opioid therapies—to align with evolving regulatory standards and changing patient preferences.
Competition also revolves around drug formulations, delivery technologies, and pricing strategies. Emerging companies introducing novel therapeutic solutions are challenging established firms, further spurring innovation. Additionally, many companies are expanding their geographic reach through collaborations and licensing agreements. The ongoing opioid crisis has accelerated efforts to develop alternative pain management therapies, intensifying market competition. This dynamic landscape fosters continuous advancements that ultimately benefit patients and healthcare providers worldwide.
Recent Developments:
- In January 2025, Vertex Pharmaceuticals received FDA approval for Journavx (suzetrigine), a novel non-opioid painkiller for moderate-to-severe acute pain. This marks the first approval of a new class of pain medication in over two decades. Journavx targets sodium channels specific to pain neurons, providing effective pain relief without the addictive risks associated with opioids. This approval represents a significant milestone in the advancement of non-opioid pain management options.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Johnson & Johnson
- Pfizer Inc.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- Novartis AG
- Grünenthal GmbH
- Mylan N.V.
- Mallinckrodt Pharmaceuticals
- Sanofi S.A.
- Allergan (AbbVie)
- AstraZeneca plc
- Endo International plc
- Bristol-Myers Squibb
- Bayer AG
- AcelRx Pharmaceuticals
GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET, BY TYPE OF PAIN- MARKET ANALYSIS, 2019 - 2032
- Acute Pain
- Chronic Pain
- Cancer Pain
- Neuropathic Pain
- Postoperative Pain
GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019 - 2032
- Opioids
- Non-Opioid Analgesics
- Adjuvant Analgesics
- Topical Analgesics
- Others
GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET, BY ADMINISTRATION ROUTE- MARKET ANALYSIS, 2019 - 2032
- Oral
- Injectable
- Transdermal
- Topical
GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
- Others
GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Pain Management Therapeutics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Pain Management Therapeutics Market Snippet by Type of Pain
2.1.2. Pain Management Therapeutics Market Snippet by Drug Class
2.1.3. Pain Management Therapeutics Market Snippet by Administration Route
2.1.4. Pain Management Therapeutics Market Snippet by End-user
2.1.5. Pain Management Therapeutics Market Snippet by Country
2.1.6. Pain Management Therapeutics Market Snippet by Region
2.2. Competitive Insights
3. Pain Management Therapeutics Key Market Trends
3.1. Pain Management Therapeutics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Pain Management Therapeutics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Pain Management Therapeutics Market Opportunities
3.4. Pain Management Therapeutics Market Future Trends
4. Pain Management Therapeutics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Pain Management Therapeutics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Pain Management Therapeutics Market Landscape
6.1. Pain Management Therapeutics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Pain Management Therapeutics Market – By Type of Pain
7.1. Overview
7.1.1. Segment Share Analysis, By Type of Pain, 2024 & 2032 (%)
7.1.2. Acute Pain
7.1.3. Chronic Pain
7.1.4. Cancer Pain
7.1.5. Neuropathic Pain
7.1.6. Postoperative Pain
8. Pain Management Therapeutics Market – By Drug Class
8.1. Overview
8.1.1. Segment Share Analysis, By Drug Class, 2024 & 2032 (%)
8.1.2. Opioids
8.1.3. Non-Opioid Analgesics
8.1.4. Adjuvant Analgesics
8.1.5. Topical Analgesics
8.1.6. Others
9. Pain Management Therapeutics Market – By Administration Route
9.1. Overview
9.1.1. Segment Share Analysis, By Administration Route, 2024 & 2032 (%)
9.1.2. Oral
9.1.3. Injectable
9.1.4. Transdermal
9.1.5. Topical
10. Pain Management Therapeutics Market – By End-user
10.1. Overview
10.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Ambulatory Surgical Centers
10.1.4. Home Care Settings
10.1.5. Others
11. Pain Management Therapeutics Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Pain Management Therapeutics Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.2.8. The U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Pain Management Therapeutics Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Pain Management Therapeutics Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Pain Management Therapeutics Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Pain Management Therapeutics Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Type of Pain, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Administration Route, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Pain Management Therapeutics Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Johnson & Johnson
12.2.2. Pfizer Inc.
12.2.3. AbbVie Inc.
12.2.4. Teva Pharmaceutical Industries Ltd.
12.2.5. Eli Lilly and Company
12.2.6. Novartis AG
12.2.7. Grünenthal GmbH
12.2.8. Mylan N.V.
12.2.9. Mallinckrodt Pharmaceuticals
12.2.10. Sanofi S.A.
12.2.11. Allergan (AbbVie)
12.2.12. AstraZeneca plc
12.2.13. Endo International plc
12.2.14. Bristol-Myers Squibb
12.2.15. Bayer AG
12.2.16. AcelRx Pharmaceuticals
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
